KRAS-targeted TCR-T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KRAS-targeted TCR-T cell therapy, covering 2025-11-25 to 2025-11-25. Get the full timeline:
Most recent: Clinical Trial Update: T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor [Phase 1]